Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Dermata Therapeutics Inc., 2 years.
Dermata Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Dermata Therapeutics Inc. | Open-market sale | −11 | $1.19 | $13 |
| Aug 21, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +12,500 | $1.50 | $18,750 |
| Aug 21, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −12,500 | $15.00 | $187,500 |
| May 20, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +50,000 | $1.50 | $75,000 |
| May 20, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $14.10 | $705,000 |
| Oct 16, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +12,500 | $1.50 | $18,750 |
| Oct 16, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −12,500 | $16.00 | $200,000 |
| Aug 20, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +12,500 | $1.50 | $18,750 |
| Aug 20, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −12,500 | $16.00 | $200,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.